Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C‑ProMeta‑1)
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
Invadopodia play a role in prostate cancer progression
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
EMT‑independent detection of circulating tumor cells in human blood samples and pre‑clinical mouse models of metastasis
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
Cancer transcriptomic profiling from rapidly enriched circulating tumor cells
Non-invasive detection of clinically significant prostate cancer using circulating tumor cells
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells